1. Home
  2. DLPN vs PASG Comparison

DLPN vs PASG Comparison

Compare DLPN & PASG Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Dolphin Entertainment Inc.

DLPN

Dolphin Entertainment Inc.

HOLD

Current Price

$1.10

Market Cap

19.1M

ML Signal

HOLD

PASG

Passage Bio Inc.

HOLD

Current Price

$5.60

Market Cap

19.2M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
DLPN
PASG
Founded
1996
2017
Country
United States
United States
Employees
N/A
27
Industry
Other Consumer Services
Biotechnology: Pharmaceutical Preparations
Sector
Consumer Discretionary
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
19.1M
19.2M
IPO Year
2008
2020

Fundamental Metrics

Financial Performance
Metric
DLPN
PASG
Price
$1.10
$5.60
Analyst Decision
Buy
Analyst Count
0
7
Target Price
N/A
$14.00
AVG Volume (30 Days)
16.3K
35.1K
Earning Date
05-15-2026
05-12-2026
Dividend Yield
N/A
N/A
EPS Growth
77.87
N/A
EPS
N/A
N/A
Revenue
$56,699,389.00
N/A
Revenue This Year
$14.73
N/A
Revenue Next Year
$7.41
N/A
P/E Ratio
N/A
N/A
Revenue Growth
9.70
N/A
52 Week Low
$0.99
$0.35
52 Week High
$1.88
$20.00

Technical Indicators

Market Signals
Indicator
DLPN
PASG
Relative Strength Index (RSI) 32.93 49.11
Support Level $1.06 $4.94
Resistance Level $1.67 $5.90
Average True Range (ATR) 0.09 0.43
MACD 0.00 0.03
Stochastic Oscillator 28.79 58.26

Price Performance

Historical Comparison
DLPN
PASG

About DLPN Dolphin Entertainment Inc.

Dolphin Entertainment Inc is an independent entertainment marketing and production company. It provides strategic marketing and publicity services to many of the top brands, both individual and corporate, in the motion picture, television, music, gaming, culinary, hospitality, and lifestyle industries. It operates in two reportable segments: Entertainment publicity and marketing and Content production. It generates the majority of its revenue from the Entertainment publicity and marketing segment which provides clients with diversified marketing services, including public relations, entertainment and hospitality content marketing, strategic marketing consulting, and content production of marketing materials.

About PASG Passage Bio Inc.

Passage Bio Inc is a clinical-stage genetic medicines company focused on improving the lives of patients with neurodegenerative diseases. Their primary focus is the development and advancement of cutting-edge, one-time gene therapies designed to target critical underlying pathologies in these conditions. The Company operates in a single reportable segment, developing and advancing genetic medicines designed to target the critical underlying pathology of neurodegenerative diseases. The pipeline having PBFT02.

Share on Social Networks: